Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 24, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 4, 2009View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionOct 29, 2009View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 28, 2009View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 26, 2009View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 1, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 11, 2009View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionJul 31, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13D/AAmendment to a SC 13D filingJul 31, 2009View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJul 30, 2009View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 8, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 24, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 24, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 24, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 24, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 24, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 24, 2009View HTMLDownload DOCDownload PDF
SC 13D/AAmendment to a SC 13D filingJun 24, 2009View HTMLDownload DOCDownload PDFDownload XLS
SC 13D/AAmendment to a SC 13D filingJun 19, 2009View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 19, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 19, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 16, 2009View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 16, 2009View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 15, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2009View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-93

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information